Company intelligence / Profile preview

AtaGenix Laboratories

Wuhan, Hubei, Chinaproduct.atagenix.com ↗

Ownership: Private
Development stage: Commercial

Overview

AtaGenix Laboratories specializes in mammalian cell protein expression, custom antibody discovery, engineering, and production. It has completed over 20,000 successful projects for more than 3,000 partners worldwide. The company accelerates R&D from early discovery to clinical studies by providing high-quality recombinant proteins and antibodies for research, diagnostics, and drug development applications[1][2].

Modalities: Recombinant proteinMonoclonal antibodyCamelid VHH antibodyBiosimilar protein
Industry: Drug Discovery Services

Partnerships

ProteoGenix Laboratories

Beyond the preview

Go deeper on AtaGenix Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AtaGenix Laboratories.

Explore the full profile